These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9512108)

  • 1. Management of systemic sclerosis: the art and science.
    Stone JH; Wigley FM
    Semin Cutan Med Surg; 1998 Mar; 17(1):55-64. PubMed ID: 9512108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical approach to scleroderma.
    White B
    Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
    Strange G; Nash P
    Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.
    Merkel PA; Clements PJ; Reveille JD; Suarez-Almazor ME; Valentini G; Furst DE;
    J Rheumatol; 2003 Jul; 30(7):1630-47. PubMed ID: 12858472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of systemic sclerosis.
    Pope JE
    Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
    J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Khanna D; Distler O; Avouac J; Behrens F; Clements PJ; Denton C; Foeldvari I; Giannini E; Huscher D; Kowal-Bielecka O; Lovell D; Matucci-Cerinic M; Mayes M; Merkel PA; Nash P; Opitz CF; Pittrow D; Rubin L; Seibold JR; Steen V; Strand CV; Tugwell PS; Varga J; Zink A; Furst DE; ;
    J Rheumatol; 2009 Oct; 36(10):2356-61. PubMed ID: 19820225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment options in systemic Sclerosis (Scleroderma).
    Stummvoll GH
    Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of scleroderma.
    Smiley JD
    Am J Med Sci; 1992 Nov; 304(5):319-33. PubMed ID: 1359785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis--challenges for clinical practice.
    McMahan ZH; Hummers LK
    Nat Rev Rheumatol; 2013 Feb; 9(2):90-100. PubMed ID: 23147899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of patients with systemic sclerosis].
    Wiesik-Szewczyk E; Olesińska M
    Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating systemic sclerosis in 2001.
    Mouthon L; Agard C
    Joint Bone Spine; 2001 Oct; 68(5):393-402. PubMed ID: 11707005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.